{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:30:30Z","timestamp":1793946630608,"version":"4.8.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009898","name":"Defense Health Agency Consortium","doi-asserted-by":"publisher","award":["HU00012520024"],"award-info":[{"award-number":["HU00012520024"]}],"id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009898","name":"Defense Health Agency Consortium","doi-asserted-by":"publisher","award":["HU00011920090"],"award-info":[{"award-number":["HU00011920090"]}],"id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eclinm.2026.104249","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:34:52Z","timestamp":1791297292000},"page":"104249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enterotoxigenic Escherichia coli hyperimmune bovine colostrum for preventing travellers\u2019 diarrhoea (TD): a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9361-2991","authenticated-orcid":false,"given":"Tahaniyat","family":"Lalani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1504-253X","authenticated-orcid":false,"given":"Nathanial K.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry Q.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda E.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Troth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylviane","family":"Defres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Rizzo-Pelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie A.","family":"Joya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cerroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0777-7475","authenticated-orcid":false,"given":"Huai-Ching","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9243-4882","authenticated-orcid":false,"given":"Ningbo","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad K.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Rimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Tribble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.104249_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2014.17006","article-title":"Traveler\u2019s diarrhea: a clinical review","volume":"313","author":"Steffen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104249_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad461","article-title":"The impact of infectious disease syndromes on activities during military travel","volume":"10","author":"Boatwright","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.eclinm.2026.104249_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1708-8305.1995.tb00615.x","article-title":"Safety, immunogenicity, and protective efficacy of the whole-Cell\/Recombinant B subunit (WC\/rBS) oral cholera vaccine against travelers' diarrhea","volume":"2","author":"Scerpella","year":"1995","journal-title":"J Travel Med"},{"key":"10.1016\/j.eclinm.2026.104249_bib4","first-page":"CD009029","article-title":"Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea","volume":"7","author":"Ahmed","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eclinm.2026.104249_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1708-8305.2012.00650.x","article-title":"Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"19","author":"Hu","year":"2012","journal-title":"J Travel Med"},{"key":"10.1016\/j.eclinm.2026.104249_bib6","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/jtm\/tax026","article-title":"Guidelines for the prevention and treatment of travelers\u2019 diarrhea: a graded expert panel report","volume":"24","author":"Riddle","year":"2017","journal-title":"J Travel Med"},{"key":"10.1016\/j.eclinm.2026.104249_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41586-024-08095-4","article-title":"Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin","volume":"635","author":"Turner","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2026.104249_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaf047","article-title":"Efficacy of bismuth subsalicylate on the prevention of travellers\u2019 diarrhoea, 2018-2023","volume":"32","author":"Angelo","year":"2025","journal-title":"J Travel Med"},{"key":"10.1016\/j.eclinm.2026.104249_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax057","article-title":"Can a galacto-oligosaccharide reduce the risk of traveller's diarrhoea? A placebo-controlled, randomized, double-blind study","volume":"24","author":"Hasle","year":"2017","journal-title":"J Travel Med"},{"key":"10.1016\/j.eclinm.2026.104249_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.advnut.2023.02.002","article-title":"Orally ingested probiotic, prebiotic, and synbiotic interventions as countermeasures for gastrointestinal tract infections in nonelderly adults: a systematic review and meta-analysis","volume":"14","author":"Fagnant","year":"2023","journal-title":"Adv Nutr"},{"key":"10.1016\/j.eclinm.2026.104249_bib14","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/00365521.2011.574726","article-title":"Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers","volume":"46","author":"Otto","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.eclinm.2026.104249_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00186-16","article-title":"Bioactive immune components of anti-diarrheagenic enterotoxigenic Escherichia coli hyperimmune bovine colostrum products","volume":"24","author":"Sears","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.eclinm.2026.104249_bib16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM198805123181904","article-title":"Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli","volume":"318","author":"Tacket","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.104249_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/514227","article-title":"Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli","volume":"177","author":"Freedman","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2026.104249_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab138","article-title":"TaqMan array card testing of participant-collected stool smears to determine the pathogen-specific epidemiology of travellers\u2019 diarrhoea","volume":"29","author":"Tisdale","year":"2022","journal-title":"J Travel Med"},{"key":"10.1016\/j.eclinm.2026.104249_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ejcn.2009.120","article-title":"A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea","volume":"64","author":"Drakoularakou","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.eclinm.2026.104249_bib21","first-page":"9","article-title":"Prevention of traveller's diarrhea: comparison of different non-antibiotic preparations","volume":"7","author":"Kollaritsch","year":"1989","journal-title":"Travel Med Int"},{"key":"10.1016\/j.eclinm.2026.104249_bib22","article-title":"Population attributable fraction","volume":"360","author":"Mansournia","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.104249_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/gut.44.2.212","article-title":"Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine","volume":"44","author":"Warny","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.eclinm.2026.104249_bib24","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.4269\/ajtmh.20-0241","article-title":"Doxycycline malaria prophylaxis impact on risk of travelers\u2019 diarrhea among international travelers","volume":"103","author":"Lago","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.eclinm.2026.104249_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12937-015-0010-7","article-title":"Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans","volume":"14","author":"Jasion","year":"2015","journal-title":"Nutr J"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702600502X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702600502X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:49:37Z","timestamp":1793944177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702600502X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"alternative-id":["S258953702600502X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104249","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enterotoxigenic Escherichia coli hyperimmune bovine colostrum for preventing travellers\u2019 diarrhoea (TD): a randomised, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104249"}}